Company intelligence / Profile preview

Washington Center for Bleeding Disorders

Seattle, Washington, United Stateswacbd.org ↗

Ownership: Private
Development stage: Commercial

Overview

WACBD is a federally funded and state-recognized Center of Excellence providing comprehensive medical care, specialized pharmacy services—including a 340B hemophilia pharmacy—and conducting clinical research in bleeding disorders. The organization offers individualized treatment plans and genetic counseling. Its expert team contributes to international research efforts in hematology.

Therapeutic areas: Hematology
Modalities: ProteinRecombinant proteinSmall molecule
Industry: Academic Hospital/University/Research

Partnerships

Seattle Children’s HospitalMary Bridge Children’s HospitalProvidence Sacred HeartBloodworks NorthwestBleeding Disorders Foundation of Washington

Beyond the preview

Go deeper on Washington Center for Bleeding Disorders.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Washington Center for Bleeding Disorders.

Explore the full profile